Markers on xenograft-initiating cells in estrogen receptor-negative breast cancer http://bit.ly/9Xhzbp. Hashtag: #cancerSC. [PubMed Citation]
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
Cancer Stem Cell News by http://cancerstemcellnews.blogspot.com/ is licensed under a Creative Commons Attribution 2.5 Canada License.
A Blog of the Cancer Stem Cell Consortium
A blog of news items related to cancer stem cells, with an emphasis on recent research and articles that are openly accessible.
Featured Post
The #cancerSC hashtag on Twitter
From the Editor : I switched some time ago to the use of Twitter, instead of this blog, as a place to post items about selected recent news...
Search This Blog
Posts
Blog Archive
-
▼
2010
(64)
-
▼
May
(8)
- Patent application involving miRNAs and CSCs
- CSC news update 2010-05-24
- An evolving concept of CSCs in tumor biology
- US Patent: Isolation and use of solid tumor stem c...
- Generic drug a potential treatment for glioblastoma?
- CSC news links 2010-05-08
- CSC news links 2010-05-01
- More about presentations at AACR10
-
▼
May
(8)
About the Editor
- Jim Till
- The editor has been a member of the Board of Directors of the Cancer Stem Cell Consortium (CSCC), based in Ottawa, Canada. The CSCC Board terminated it's role in 2016.
Editor's Blog List
Links to Related Sites
Stats for this blog
This blog was initiated on August 28, 2008.
Stats at 6 months (Mar 2009): 2,523 visitors, 3,712 visits and 6,703 pageviews. Traffic sources: 40% via search engines, 40% via referring sites, 20% direct traffic.
First year (Aug 2009): 8,172 visitors, 12,249 visits, 19,730 pageviews. Traffic sources: 53% via search engines, 29% via referring sites, 17% direct traffic.
Stats at 6 months (Mar 2009): 2,523 visitors, 3,712 visits and 6,703 pageviews. Traffic sources: 40% via search engines, 40% via referring sites, 20% direct traffic.
First year (Aug 2009): 8,172 visitors, 12,249 visits, 19,730 pageviews. Traffic sources: 53% via search engines, 29% via referring sites, 17% direct traffic.
Second yearAug 2010): 11,716 visitors, 20,180 visits, 29,915 pageviews. Traffic sources: 65% via search engines, 15% via referring sites, 20% direct traffic.
Third year (Aug 2011): 10,866 visitors, 17,144 visits, 23,610 pageviews. Traffic sources: 60% via search engines, 13% via referring sites, 27% direct traffic.
Fourth year (Aug 2012): 8,088 visitors, 11,046 visits, 14,023 pageviews. Traffic sources: 67% via search engines, 9% via referring sites, 24% direct traffic.
Fifth year (Aug 2013): 1,992 visitors, 2,791 visits, 3,712 pageviews. Traffic sources: 53% via search engines, 18.5 % via referring sites, 28.5% direct traffic.
Sixth year (Aug 2014): 805 visitors, 1,229 visits, 1,573 pageviews. Traffic sources: data not available.
Seventh year (Aug 2015): 1,024 visitors, 1,350 visits, 1,735 pageviews.
Eighth year (Aug 2016): 1,066 users, 756 sessions, 1,594 pageviews.
Nineth year (Aug 2017): 609 users, 757 sessions, 1,528 pageviews.
Tenth year (Aug 2018): 584 users, 616 sessions, 775 pageviews.
Eleventh year (Aug 2019): 299 users, 314 sessions, 383 pageviews.
Third year (Aug 2011): 10,866 visitors, 17,144 visits, 23,610 pageviews. Traffic sources: 60% via search engines, 13% via referring sites, 27% direct traffic.
Fourth year (Aug 2012): 8,088 visitors, 11,046 visits, 14,023 pageviews. Traffic sources: 67% via search engines, 9% via referring sites, 24% direct traffic.
Fifth year (Aug 2013): 1,992 visitors, 2,791 visits, 3,712 pageviews. Traffic sources: 53% via search engines, 18.5 % via referring sites, 28.5% direct traffic.
Sixth year (Aug 2014): 805 visitors, 1,229 visits, 1,573 pageviews. Traffic sources: data not available.
Seventh year (Aug 2015): 1,024 visitors, 1,350 visits, 1,735 pageviews.
Eighth year (Aug 2016): 1,066 users, 756 sessions, 1,594 pageviews.
Nineth year (Aug 2017): 609 users, 757 sessions, 1,528 pageviews.
Tenth year (Aug 2018): 584 users, 616 sessions, 775 pageviews.
Eleventh year (Aug 2019): 299 users, 314 sessions, 383 pageviews.
Creative Commons License
Cancer Stem Cell News by http://cancerstemcellnews.blogspot.com/ is licensed under a Creative Commons Attribution 2.5 Canada License.
No comments:
Post a Comment